---
figid: PMC9116919__AD-13-3-673-g2
figtitle: 'Vascular Calcification in Chronic Kidney Disease: An Update and Perspective'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
pmcid: PMC9116919
filename: AD-13-3-673-g2.jpg
figlink: /pmc/articles/PMC9116919/figure/F2-ad-13-3-673/
number: F2
caption: Multifactorial signaling is involved in VSMC osteo/chondrogenic transdifferentiation
  regulation. Various molecules directly or indirectly mediate the VSMC osteo/chondrogenic
  transdifferentiation process via cross-talking interaction. For example, phosphate
  and ECM components activate the TLR4/NF-κB signaling pathway to upregulate the osteogenic
  transcriptional factors Runx2 and BMP2. Moreover, calcium and phosphate activate
  the Pit-1 signaling pathway and interact with the IL-6 and PTH signaling pathways.
  PTH binds to PTH1R and ignites NF-κB signaling pathways through ERK1/2, integrating
  TNF-α stimulation. Additionally, TNF-α stimulates AP-1 via c-FOS to increase osteo-/chondrogenic
  genes expression, coordinating the IL-6/sIL-6R/STAT3/p53/p21 pathways to trigger
  VSMC transdifferentiation. As an interfering agent, IMD1-53 upregulates Sirt1 by
  activating the cAMP/PKA signaling pathway or upregulating α-klotho levels via the
  CRLR/RAMP3 complex to inhibit Wnt/β-catenin signaling. miR-30B promotes the MMP
  and autophagy-related to the mTOR signal pathway, and crosstalk exists between this
  signaling pathway and NF-κB. PTH, parathyroid hormone; TLR4, toll-like receptor
  4; ERK1/2, Extracellular regulated protein kinases 1/2; PTH1R, parathyroid hormone
  1 receptor; sIL-6R, soluble IL-6 receptor; STAT3, signal transducer and activator
  of transcription 3; IMD1-53, intermedin 1-53; CRLR, calcitonin receptor-like receptor;
  RAMP3, receptor activity-modifying protein-3; and MMP, mitochondrial membrane potential.
papertitle: 'Vascular Calcification in Chronic Kidney Disease: An Update and Perspective.'
reftext: Si-Chong Ren, et al. Aging Dis. 2022 Jun;13(3):673-697.
year: '2022'
doi: 10.14336/AD.2021.1024
journal_title: Aging and Disease
journal_nlm_ta: Aging Dis
publisher_name: JKL International LLC
keywords: vascular calcification | chronic kidney disease | aging | metabolism | biomarker
automl_pathway: 0.9153917
figid_alias: PMC9116919__F2
figtype: Figure
organisms_ner:
- Rattus norvegicus
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC9116919__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9116919__AD-13-3-673-g2.html
  '@type': Dataset
  description: Multifactorial signaling is involved in VSMC osteo/chondrogenic transdifferentiation
    regulation. Various molecules directly or indirectly mediate the VSMC osteo/chondrogenic
    transdifferentiation process via cross-talking interaction. For example, phosphate
    and ECM components activate the TLR4/NF-κB signaling pathway to upregulate the
    osteogenic transcriptional factors Runx2 and BMP2. Moreover, calcium and phosphate
    activate the Pit-1 signaling pathway and interact with the IL-6 and PTH signaling
    pathways. PTH binds to PTH1R and ignites NF-κB signaling pathways through ERK1/2,
    integrating TNF-α stimulation. Additionally, TNF-α stimulates AP-1 via c-FOS to
    increase osteo-/chondrogenic genes expression, coordinating the IL-6/sIL-6R/STAT3/p53/p21
    pathways to trigger VSMC transdifferentiation. As an interfering agent, IMD1-53
    upregulates Sirt1 by activating the cAMP/PKA signaling pathway or upregulating
    α-klotho levels via the CRLR/RAMP3 complex to inhibit Wnt/β-catenin signaling.
    miR-30B promotes the MMP and autophagy-related to the mTOR signal pathway, and
    crosstalk exists between this signaling pathway and NF-κB. PTH, parathyroid hormone;
    TLR4, toll-like receptor 4; ERK1/2, Extracellular regulated protein kinases 1/2;
    PTH1R, parathyroid hormone 1 receptor; sIL-6R, soluble IL-6 receptor; STAT3, signal
    transducer and activator of transcription 3; IMD1-53, intermedin 1-53; CRLR, calcitonin
    receptor-like receptor; RAMP3, receptor activity-modifying protein-3; and MMP,
    mitochondrial membrane potential.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tnf
  - Tnfrsf1a
  - Fos
  - Pth
  - Il6
  - Pth1r
  - Mapk3
  - Mapk1
  - Stat3
  - Runx2
  - Sox9
  - Msx2
  - Tlr4
  - Myd88
  - Nfkb1
  - Tp53
  - Kras
  - Pik3cg
  - Akt1
  - Ctnnb1
  - Calcrl
  - Pamr1
  - Wnt2
  - Sirt1
  - Ptpra
  - Lrp5
  - Ogt
  - COX1
  - Pdlim3
  - Mir30b
  - Mtor
  - Tnfrsf1b
  - Ptrh1
  - Jun
  - Trp53
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Pik3r1
  - Zmym2
  - Dtl
  - Lrp1
  - Mvp
  - Txlng
  - Gsk3b
  - Col2a1
  - alp
  - Alpl
  - Ccl21a
  - Ccl27a
  - Slpi
  - Asrgl1
  - Atrnl1
  - Limk2
  - TNF
  - TNFRSF1A
  - FOS
  - PRKG1
  - PTH
  - PTRH2
  - IL6
  - PTH1R
  - MAPK3
  - MAPK1
  - DIRAS3
  - STAT3
  - FOSB
  - JUN
  - JUNB
  - JUND
  - RUNX2
  - SOX9
  - MSX2
  - SP7
  - TLR4
  - MYD88
  - NFKB1
  - TP53
  - TP63
  - TP73
  - HNF4A
  - LEF1
  - TCF7
  - TCF7L1
  - TCF7L2
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - CTNNB1
  - CALCRL
  - ZMYM2
  - PAMR1
  - DTL
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - SIRT1
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - RPSA
  - LRP1
  - PTPRA
  - MVP
  - LRP5
  - GSK3A
  - GSK3B
  - OGT
  - EOGT
  - POMGNT1
  - POMGNT2
  - COX3
  - ALPP
  - ATHS
  - SLPI
  - CCL27
  - ATRNL1
  - PDLIM3
  - NAT10
  - ASRGL1
  - MIR30B
  - MTOR
---
